other material
confidence high
sentiment neutral
materiality 0.20
Aura Biosciences amends charter and bylaws upon IPO; authorizes 150M common shares
Aura Biosciences, Inc.
- Authorized 150 million shares of common stock and 10 million shares of undesignated preferred stock.
- Eliminated all references to prior series of preferred stock from charter.
- Amended bylaws effective Oct 28, 2021: removed stockholder written consent and special meeting rights.
- Established procedures for stockholder proposals and director nominations in bylaws.
- All changes were previously disclosed in IPO registration statement S-1.